Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic Acid for Statin-Induced Impaired Glucose Tolerance
NCT06684106Recruiting
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Nov 2024
- Primary completion
- Nov 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial in glucose intolerance comparing Ursodeoxycholic acid group with placebo group (2 arms). Primary endpoint: Glycosylated hemoglobin at 6 months. Started Nov 2024; status: recruiting.
02
Drugs
ursodeoxycholic acid
03
Conditions
glucose intolerance
Beyond the preview
Go deeper on NCT06684106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06684106.